Pressor Hormone Profile During Stress in Hypertension: Does Vasopressin Interfere with Left Ventricular Hypertrophy?

References

• Savage D D, Drayer J IM, Henry W L. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979; 59: 623–632
   PubMed Web of Science ®Google Scholar
• Hammond I W, Devereux R B, Alderman M H, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639–650
   PubMed Web of Science ®Google Scholar
• Laufer E, Jennings G L, Korner P I, et al. Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension. Hypertension 1989; 13: 151–162
   PubMed Web of Science ®Google Scholar
• Casale P N, Devereux R B, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–178
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison R J, Savage D D, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566
   PubMed Web of Science ®Google Scholar
• Katz A M. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. New Engl J Med 1990; 322: 100–110
   PubMed Web of Science ®Google Scholar
• Daemen M JAP, Lombardi D M, Bosman F T, Schwartz S M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Research 1991; 68: 450–456
   PubMed Web of Science ®Google Scholar
• Wesseling H, De Graeff P A, Van Gilst W H, Kingma J H, De Langen C D. Cardiac arrhythmias - a new indication for angiotensin-converting enzyme inhibitors. J Hum Hypertens 1989; 3(Suppl 1)89–95
   PubMedGoogle Scholar
• The 1988 Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023–1038
   PubMed Web of Science ®Google Scholar
• Bruce R A, Hornstein T R. Exercise, stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 1979; 11: 371–390
   Google Scholar
• Sealy J E, Gerten-Banes J, Laragh J H. The renin system: variations in man measured by radioimmunoassay or bioassay. Kidney Int 1972; 1: 240–253
   PubMed Web of Science ®Google Scholar
• Davis G C, Kissinger P T, Sharp R E. Strategies for determination of serum or plasma norepinephrine by reverse phase liquid chromatography. Anal Chem 1981; 53: 156–159
   PubMed Web of Science ®Google Scholar
• LaRochelle F T, Jr, North W G, Stern P. A new extraction of arginine vasopressin from blood: the use of octadecasilyl-silica. Pflugers Archiv. 1980; 387: 79–81
   PubMed Web of Science ®Google Scholar
• Tajik A J, Seward J B, Hagler D J, Mair D D, Lie J T. Two dimensional real time ultrasound imaging of the heart and great vessels, Technique, image, orientation, structure, identification and validation. Mayo Clin. Proc. 1978; 53: 271–303
   PubMed Web of Science ®Google Scholar
• Nishimura R A, Fletheer A M, Callaham M J, Benassi R C, Seward J B, Tajik A J. Doppler echocardiography: Theory, instrumentation, technique and application. Mayo Clin. Proc. 1988; 60: 321–343
   Google Scholar
• Schulman S P, Weiss J L, Becker L C, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med; 1990; 322: 1350–6
   PubMed Web of Science ®Google Scholar
• Azizi M, Levy B, Salzmann J-L, Cerol M L, Poitevin P, Menard J, Michel J-B. Long-term cardiac effects of hypotensive agents in normotensive mature rats: Comparison of beta-blocking agent and converting enzyme inhibition. J of Cardiovascular Pharmacology 1989; 13: 691–701
   PubMed Web of Science ®Google Scholar
• Pfeffer M A, Pfeffer J M. Reversing cardiac hypertrophy in hypertension. N Engl J Med; 1990; 322: 1388–1390
   PubMed Web of Science ®Google Scholar
• Corea L, Bentivoglio M, Verdecchia P, Motolese M. Plasma norepinephrine and left ventricular hypertrophy in systemic hypertension. Am J Cardiol 1984; 53: 1299–1303
   PubMed Web of Science ®Google Scholar
• Ganguly P K, Lee S-L, Beamish R E, Dhalla N S. Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy. Am Heart J 1989; 118: 520
   PubMed Web of Science ®Google Scholar
• Zierhut W, Zimmer H-G. Significance of myocardial alpha and beta adrenoceptors in catecholamine-induced cardiac hypertrophy. Circulation Research 1989; 65: 1417–1425
   PubMed Web of Science ®Google Scholar
• Newling R P, Fletcher P J, Contis M, Shaw J. Noradrenaline and cardiac hypertrophy in the rat: changes in morphology, blood pressure and ventricular performance. J Hypertens 1989; 7: 561–7
   PubMed Web of Science ®Google Scholar
• Nakano J. Studies on the cardiovascular effects of synthetic vasopressin. J Pharmacol Exp Therap 1967; 157: 19–31
   PubMed Web of Science ®Google Scholar
• Varma S, Jaju B, Bhargava K. Mechanism of vasopressin-induced bradycardia in dogs. Circ Res 1969; 24: 787–792
   PubMed Web of Science ®Google Scholar
• Heyndrickx B, Boettcher D, Vatner S. Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 1976; 231: 1579–1587
   PubMed Web of Science ®Google Scholar
• Freer R J, Rappamo A J, Peach M J. Mechanism of the positive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res 1976; 66: 178
   Google Scholar
• Os I, Kjeldsen S E, Skjoto J, Westheim A, Lande K, Aakesson I, Frederichsen P, Leren P, Hjermann I, Eide I K. Increased plasma vasopressin in low renin essential hypertension. Hypertension 1986; 8: 506–513
   PubMed Web of Science ®Google Scholar
• Bursztyn M, Bresnahan M, Gavras I, Gavras H. Pressor hormones in elderly hypertensive persons racial differences. Hypertension 1990; 15(suppl I)I-88–I-92
   Google Scholar
• Bakris G L, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Pressor role of vasoprsssin in black hypertensives (Abstr). Presented to the 45th Annual Conference of the Council for High Blood Pressure Research, Chicago, IL, Sept, 1991
   Google Scholar
• Sudhir K, Woods R L, Jennings G L, Nelson L A, Laufer E, Korner P I. Exaggerated atrial natriuretic peptide release during acute exercise in essential hypertension. J Hum Hypertens 1988; 299–304
   PubMed Web of Science ®Google Scholar
• Papademetriou V, Notargiacomo A, Sethi E, Costello R, Fletcher R, Freis E D. Exercise blood pressure response and left ventricular hypertrophy. Am J Hypertens 1989; 2: 114–116
   PubMed Web of Science ®Google Scholar
• Tubau J F, Szlachcic J, Braun S, Massie B M. Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy. Hypertension 1989; 14: 1–8
   PubMed Web of Science ®Google Scholar
• Kohlmann O, Bresnahan M, Gavras H. Central and peripheral indices of sympathetic activity following blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats. Hypertension 1984; 6(Suppl 1)1–6
   Google Scholar
• Campbell D J. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79: 1–6
   PubMed Web of Science ®Google Scholar
• Makrides S C, Mulinari R, Zannis V I, Gavras H. Regulation of renin gene expression in hypertensive rats. Hypertension 1988; 12: 405–410
   PubMed Web of Science ®Google Scholar